[Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].

[1]  M. Dougados,et al.  Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. , 2015, The New England journal of medicine.

[2]  B. Swoboda,et al.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.6 Invasive therapy]. , 2014, Zeitschrift fur Rheumatologie.

[3]  A. Heiligenhaus,et al.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8 Therapy, 8.1 Treatment concept, 8.2 Therapy targets and strategy]. , 2014, Zeitschrift fur Rheumatologie.

[4]  J. Braun,et al.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 10 Patient information]. , 2014, Zeitschrift fur Rheumatologie.

[5]  W. Mau,et al.  DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen , 2014, Zeitschrift für Rheumatologie.

[6]  B. Swoboda,et al.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.3 Nonpharmaceutical therapeutic measures]. , 2014, Zeitschrift fur Rheumatologie.

[7]  W. Mau,et al.  DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen , 2014, Zeitschrift für Rheumatologie.

[8]  J. Chenot,et al.  DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen , 2014, Zeitschrift für Rheumatologie (Print).

[9]  B. Swoboda,et al.  DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen , 2014, Zeitschrift für Rheumatologie.

[10]  J. Braun,et al.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 6 Diagnostics]. , 2014, Zeitschrift fur Rheumatologie.

[11]  A. Stallmach,et al.  DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen , 2014, Zeitschrift für Rheumatologie.

[12]  J. Braun,et al.  [ASAS recommendations on the use of TNF inhibitors for patients with axial spondyloarthritis : evaluation of the 2010 update in the German-speaking area]. , 2013, Zeitschrift fur Rheumatologie.

[13]  E. Märker-Hermann,et al.  Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. , 2012, Arthritis and rheumatism.

[14]  M. Dougados,et al.  2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis , 2011, Annals of the rheumatic diseases.

[15]  L. Carmona,et al.  Prevalence of Vertebral Fractures by Semiautomated Morphometry in Patients with Ankylosing Spondylitis , 2011, The Journal of Rheumatology.

[16]  D. M. van der Heijde,et al.  Asas/who Icf Core Sets for Ankylosing Spondylitis (as): How to Classify the Impact of as on Functioning and Health Extended Report , 2022 .

[17]  E. Märker-Hermann,et al.  The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. , 2009, Arthritis and rheumatism.

[18]  J. Sieper,et al.  The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research , 2008, Annals of the rheumatic diseases.

[19]  Andreas Krause,et al.  Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial , 2006, Annals of the rheumatic diseases.

[20]  J. Braun,et al.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers. , 2000, The Journal of rheumatology.

[21]  M. Dougados,et al.  Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. , 1999, The Journal of rheumatology.

[22]  M. Dougados,et al.  Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. , 1999, The Journal of rheumatology.

[23]  A. Calin,et al.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. , 1994, The Journal of rheumatology.

[24]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[25]  B. Swoboda,et al.  DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen , 2014, Zeitschrift für Rheumatologie.

[26]  M. Dougados,et al.  Arthritis 2 Spondyloarthritis , 2011 .

[27]  A. Boonen,et al.  Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. , 2010, Rheumatology.